NCT00427349 2023-07-05AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine TumorsEastern Cooperative Oncology GroupPhase 2 Completed46 enrolled 7 charts
NCT00574951 2018-01-11AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerGOG FoundationPhase 2 Terminated23 enrolled 9 charts